Purpose This review provides an update on the current clinical, epidemiological and
pathophysiological evidence alongside the diagnostic, prevention and treatment approach …

Chemotherapy-induced peripheral neuropathy (CIPN) is one of the most frequent side
effects caused by antineoplastic agents, with a prevalence from 19% to over 85%. Clinically …

Nearly 60 years ago thalidomide was prescribed to treat morning sickness in pregnant
women. What followed was the biggest man‐made medical disaster ever, where over …

The heterogeneity and complex nature of Alzheimer's disease (AD) is attributed to several
genetic risk factors and molecular culprits. The slow pace and increasing failure rate of …

Thalidomide is a potent teratogen that induces a range of birth defects, most commonly of
the developing limbs. The mechanisms underpinning the teratogenic effects of thalidomide …

MicroRNAs have been implicated in regulating diverse cellular pathways. Emerging
evidence indicates that miR-143 plays causal roles in cancer tumorigenesis as a tumor …

In recent days, vanadium complexes and nanoparticles have received sustainable attention
owing to their vast applications in different fields. In the present study, we report a facile …

Despite the recent discovery that thalidomide causes limb defects by targeting highly
angiogenic, immature blood vessels, several challenges still remain and new ones have …

Nanotechnology has emerged as a promising approach for the targeted delivery of
therapeutic agents while improving their efficacy and safety. As a result, nanomaterial …

Thalidomide remains notorious as a result of the damage it caused to children born to
mothers who used it to treat morning sickness between 1957 and 1961. The re-emergence …